v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 5 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Jul. 31, 2025
Dec. 31, 2024
Jul. 31, 2024
Operating activities:                        
Net loss $ (284) $ (163) $ (42) $ (39) $ (49) $ (101) $ (447) $ (81)   $ (222)   $ (113)
Adjustments to reconcile net loss to net cash used in operating activities:                        
Extinguishment of accounts payable                 (118)
Changes in operating assets and liabilities:                        
Prepaid expenses         4 (11) (4) 9   5   7
Accounts payable and accrued expenses         (5) (19) 161 (8)   37   (12)
Accrued interest - related parties         28 24 (46) 32   63   54
Cash used in operating activities         (22) (69) (336) (48)   (117)   (182)
Financing activities:                        
Proceeds from notes payable - related parties         25 55 400 40   95   200
Proceeds from convertible note             810        
Payment of notes payable             (720)        
Cash provided by financing activities         25 55 490 40   95   200
Net decrease in cash and cash equivalents         3 (14) 154 (8)   (22)   18
Cash and cash equivalents at beginning of the year   6   11 3 25 6 11 $ 11 25   7
Cash and cash equivalents at the end of the year 160   3   6 11 160 3 6 $ 3 $ 11 $ 25
Gravitics Inc [Member]                        
Operating activities:                        
Net loss (5,215) (19,295) (3,761) (1,775)     (24,510) (5,536) (11,699)   (9,048)  
Adjustments to reconcile net loss to net cash used in operating activities:                        
Depreciation and amortization             78 91 178   178  
Change in right-of-use assets             284 266 541   512  
Cash interest paid on convertible promissory notes             (80) (306) (367)   (749)  
Non-cash interest expense on short term borrowings             40        
Change in fair value of convertible promissory notes   620       3,449 890 1,858   1,246  
Change in fair value of warrant liabilities   528       8,462 953 1,985   87  
Change in fair value of SAFE liabilities   454       643 (129) (1,159)   1,108  
Gain on extinguishment of unsecured promissory note                   (186)  
Stock-based compensation             223 683 1,364   1,508  
Changes in operating assets and liabilities:                        
Unbilled revenues             30 (393) 196   (226)  
Prepaid expenses             (161) 33 (223)   (57)  
Accounts payable             (351) 142 1,253   380  
Accrued expenses and other current liabilities             110 (176) 272   (241)  
Deferred revenues             4,225 161    
Operating lease liabilities             (215) (187) (384)   (334)  
Cash used in operating activities             (7,773) (3,669) (6,024)   (5,822)  
Investing activities:                        
Purchases of property and equipment             (315) (23) (38)   (71)  
Cash used in investing activities             (315) (23) (38)   (71)  
Financing activities:                        
Proceeds from issuance of SAFE instruments                   3,057  
Proceeds from issuance of Series A-I redeemable convertible preferred stock             10,950        
Payment of Series A-I redeemable convertible preferred stock issuance costs             (245)        
Payment of deferred S-1 offering costs             (50)        
Proceeds from issuance upon exercise of common stock warrants             52        
Proceeds from issuance of common stock upon exercise of stock options             5        
Proceeds from issuance of SAFE instruments and pre-funded warrants             3,655 3,655    
Proceeds from advance subscriptions                 1,650    
Proceeds from issuance of common stock upon exercise of pre-funded warrants             7 7    
Proceeds from short-term borrowings                 170    
Repayment of short-term borrowing principal             (73) (100)    
Cash provided by financing activities             10,639 3,662 5,382   3,057  
Net decrease in cash and cash equivalents             2,551 (30) (680)   (2,836)  
Cash and cash equivalents at beginning of the year   $ 183   $ 863     183 863 863   3,699  
Cash and cash equivalents at the end of the year $ 2,734   $ 833   $ 183 $ 863 2,734 833 183   863  
Supplemental cash flow information:                        
Interest paid             86 185 380   802  
Supplemental non-cash investing and financing activities:                        
Conversion of convertible promissory note into common and preferred stock                   873  
Reclassification of warrant liability to equity                   $ 71  
Conversion of SAFE instruments into Series A-I and Series A-II redeemable convertible preferred stock             10,752        
Conversion of convertible promissory notes and default interest into Series A-I and Series A-III redeemable convertible preferred stock             9,108        
Series A issuance costs funded through issuance of common stock warrants             52        
Deferred Series A redeemable convertible preferred stock offering costs reclassified as a reduction of offering proceeds             296        
Reclassification of subscription liability to Series A-I redeemable convertible preferred stock             1,650        
Reclassification of warrant liabilities to additional paid-in capital             11,448        
Proceeds receivable from exercise of common stock warrants             10        
Deferred offering costs included in accrued expenses and other current liabilities             $ 185